On June 24, 2021, the Get the Medications Right (GTMRx) Institute hosted its third executive roundtable made up of key stakeholders from various sectors, including payer and employer groups. The virtual event included three major topic presentations together with a discussion, concluding with a reactor panel as listed in the text that follows. The goal of the discussion was to gain insights on regulatory and policy trends that inform payment and policy strategies in order to advance medication optimization in team-based care. ACCP member and Past President Curtis Haas, Pharm.D., FCCP, presented on “Measures to Motivate Adoption,” prompting a rich discussion on the current thinking and the further work needed to develop meaningful metrics to scale and expand comprehensive medication management services, as well as improve patient outcomes and provide value to the team-based care model and health system.

Curtis Haas, Pharm.D., FCCP
Chief Pharmacy Officer
University of Rochester Medical Center, New York

Welcome and Introductions

• Paul Grundy, M.D., President, GTMRx Institute
• Susan Dentzer, Senior Policy Fellow, Robert J. Margolis Center for Health Policy at Duke University

• Introduction by Brian Litten, J.D., Chief Strategic Growth Officer, Tabula Rasa HealthCare; GTMRx Pharmacogenomics Payment and Policy Taskforce Co-Lead
• Andrew MacPherson, Managing Partner, Healthsperien, LLC

• Introduction by Kathy Pham, Pharm.D., BCPPS, Policy and Professional Affairs Director, American College of Clinical Pharmacy (ACCP); GTMRx Payment and Policy Solutions Workgroup Co-Lead
• Curtis Haas, Pharm.D., FCCP, Chief Pharmacy Officer, University of Rochester Medical Center in New York

• Introduction by Kasey Thompson, Pharm.D., M.S., MBA, Chief Operating Officer & SVP, American Society of Health-System Pharmacists; GTMRx Practice and Care Delivery Transformation Workgroup Co-Lead
• Amy Bassano, Deputy Director of the Center for Medicare and Medicaid Innovation (CMMI) at the Centers for Medicare & Medicaid Services

• Matt Salo, Executive Director, National Association of Medicaid Directors (NAMD)
• Allan Goroll, M.D., Professor of Medicine, Harvard Medical School, Massachusetts General Hospital

The roundtable discussion addressed the following key questions:

• How do we drive demand for services that offer value and motivate use of comprehensive and integrated services that manage chronic conditions while encouraging and rewarding appropriate and effective medication use?
• What payment models do we use to support interprofessional, team-based care?
• What payment and policy strategies are working in the real world?
• How do we think about quality measures in a value-based payment environment?
• How are public and private payers changing to meet new demands?
• How is CMS changing payment models to meet new demands such as lower-cost, higher-quality, appropriate care?

The event was moderated by Susan Dentzer, who led the robust discussions that will inform the work of GTMRx. For information on GTMRx initiatives and access to GTMRx resources for advancing medication optimization, become a signing member at https://gtmr.org/become-a-signing-member/. If you are currently a GTMRx signing member, learn more about the workgroups in which you can become further engaged.